Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation

Protein arginine methyltransferases (PRMTs) are required for the regulation of RNA processing factors. Type I PRMT enzymes catalyze mono- and asymmetric dimethylation; Type II enzymes catalyze mono- and symmetric dimethylation. To understand the specific mechanisms of PRMT activity in splicing regul...

Full description

Bibliographic Details
Main Authors: Maxim I Maron, Alyssa D Casill, Varun Gupta, Jacob S Roth, Simone Sidoli, Charles C Query, Matthew J Gamble, David Shechter
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2022-01-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/72867
_version_ 1818019168140656640
author Maxim I Maron
Alyssa D Casill
Varun Gupta
Jacob S Roth
Simone Sidoli
Charles C Query
Matthew J Gamble
David Shechter
author_facet Maxim I Maron
Alyssa D Casill
Varun Gupta
Jacob S Roth
Simone Sidoli
Charles C Query
Matthew J Gamble
David Shechter
author_sort Maxim I Maron
collection DOAJ
description Protein arginine methyltransferases (PRMTs) are required for the regulation of RNA processing factors. Type I PRMT enzymes catalyze mono- and asymmetric dimethylation; Type II enzymes catalyze mono- and symmetric dimethylation. To understand the specific mechanisms of PRMT activity in splicing regulation, we inhibited Type I and II PRMTs and probed their transcriptomic consequences. Using the newly developed Splicing Kinetics and Transcript Elongation Rates by Sequencing (SKaTER-seq) method, analysis of co-transcriptional splicing demonstrated that PRMT inhibition resulted in altered splicing rates. Surprisingly, co-transcriptional splicing kinetics did not correlate with final changes in splicing of polyadenylated RNA. This was particularly true for retained introns (RI). By using actinomycin D to inhibit ongoing transcription, we determined that PRMTs post-transcriptionally regulate RI. Subsequent proteomic analysis of both PRMT-inhibited chromatin and chromatin-associated polyadenylated RNA identified altered binding of many proteins, including the Type I substrate, CHTOP, and the Type II substrate, SmB. Targeted mutagenesis of all methylarginine sites in SmD3, SmB, and SmD1 recapitulated splicing changes seen with Type II PRMT inhibition, without disrupting snRNP assembly. Similarly, mutagenesis of all methylarginine sites in CHTOP recapitulated the splicing changes seen with Type I PRMT inhibition. Examination of subcellular fractions further revealed that RI were enriched in the nucleoplasm and chromatin. Taken together, these data demonstrate that, through Sm and CHTOP arginine methylation, PRMTs regulate the post-transcriptional processing of nuclear, detained introns.
first_indexed 2024-04-14T07:47:46Z
format Article
id doaj.art-45b87284ee8349d28110b43dc16d75b2
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-14T07:47:46Z
publishDate 2022-01-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-45b87284ee8349d28110b43dc16d75b22022-12-22T02:05:16ZengeLife Sciences Publications LtdeLife2050-084X2022-01-011110.7554/eLife.72867Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylationMaxim I Maron0https://orcid.org/0000-0001-7809-5888Alyssa D Casill1Varun Gupta2https://orcid.org/0000-0001-5330-0486Jacob S Roth3https://orcid.org/0000-0003-0521-8677Simone Sidoli4https://orcid.org/0000-0001-9073-6641Charles C Query5https://orcid.org/0000-0002-7692-2496Matthew J Gamble6https://orcid.org/0000-0002-8107-0523David Shechter7https://orcid.org/0000-0001-9388-6004Department of Biochemistry, Albert Einstein College of Medicine, Bronx, United StatesDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, United StatesDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, United StatesDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, United StatesDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, United StatesDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, United StatesDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, United States; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, United StatesDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, United StatesProtein arginine methyltransferases (PRMTs) are required for the regulation of RNA processing factors. Type I PRMT enzymes catalyze mono- and asymmetric dimethylation; Type II enzymes catalyze mono- and symmetric dimethylation. To understand the specific mechanisms of PRMT activity in splicing regulation, we inhibited Type I and II PRMTs and probed their transcriptomic consequences. Using the newly developed Splicing Kinetics and Transcript Elongation Rates by Sequencing (SKaTER-seq) method, analysis of co-transcriptional splicing demonstrated that PRMT inhibition resulted in altered splicing rates. Surprisingly, co-transcriptional splicing kinetics did not correlate with final changes in splicing of polyadenylated RNA. This was particularly true for retained introns (RI). By using actinomycin D to inhibit ongoing transcription, we determined that PRMTs post-transcriptionally regulate RI. Subsequent proteomic analysis of both PRMT-inhibited chromatin and chromatin-associated polyadenylated RNA identified altered binding of many proteins, including the Type I substrate, CHTOP, and the Type II substrate, SmB. Targeted mutagenesis of all methylarginine sites in SmD3, SmB, and SmD1 recapitulated splicing changes seen with Type II PRMT inhibition, without disrupting snRNP assembly. Similarly, mutagenesis of all methylarginine sites in CHTOP recapitulated the splicing changes seen with Type I PRMT inhibition. Examination of subcellular fractions further revealed that RI were enriched in the nucleoplasm and chromatin. Taken together, these data demonstrate that, through Sm and CHTOP arginine methylation, PRMTs regulate the post-transcriptional processing of nuclear, detained introns.https://elifesciences.org/articles/72867PRMT5PRMT1retained detained intronsRNA processingsnRNPA549
spellingShingle Maxim I Maron
Alyssa D Casill
Varun Gupta
Jacob S Roth
Simone Sidoli
Charles C Query
Matthew J Gamble
David Shechter
Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation
eLife
PRMT5
PRMT1
retained detained introns
RNA processing
snRNP
A549
title Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation
title_full Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation
title_fullStr Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation
title_full_unstemmed Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation
title_short Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation
title_sort type i and ii prmts inversely regulate post transcriptional intron detention through sm and chtop methylation
topic PRMT5
PRMT1
retained detained introns
RNA processing
snRNP
A549
url https://elifesciences.org/articles/72867
work_keys_str_mv AT maximimaron typeiandiiprmtsinverselyregulateposttranscriptionalintrondetentionthroughsmandchtopmethylation
AT alyssadcasill typeiandiiprmtsinverselyregulateposttranscriptionalintrondetentionthroughsmandchtopmethylation
AT varungupta typeiandiiprmtsinverselyregulateposttranscriptionalintrondetentionthroughsmandchtopmethylation
AT jacobsroth typeiandiiprmtsinverselyregulateposttranscriptionalintrondetentionthroughsmandchtopmethylation
AT simonesidoli typeiandiiprmtsinverselyregulateposttranscriptionalintrondetentionthroughsmandchtopmethylation
AT charlescquery typeiandiiprmtsinverselyregulateposttranscriptionalintrondetentionthroughsmandchtopmethylation
AT matthewjgamble typeiandiiprmtsinverselyregulateposttranscriptionalintrondetentionthroughsmandchtopmethylation
AT davidshechter typeiandiiprmtsinverselyregulateposttranscriptionalintrondetentionthroughsmandchtopmethylation